Elevated L/R-type pyruvate kinase (PKLR) levels are associated with NAFLD progression: thus, inhibition of PKLR lowers liver triglyceride and cholesterol levels and improves insulin sensitivity in mice models (Krishnan et al., 2018). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.